Logo image of PHI

PLDT INC-SPON ADR (PHI) Stock Fundamental Analysis

USA - NYSE:PHI - US69344D4088 - ADR

19 USD
+0.32 (+1.71%)
Last: 10/3/2025, 8:04:00 PM
19 USD
0 (0%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

5

Taking everything into account, PHI scores 5 out of 10 in our fundamental rating. PHI was compared to 22 industry peers in the Wireless Telecommunication Services industry. PHI has an excellent profitability rating, but there are concerns on its financial health. PHI is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year PHI was profitable.
PHI had a positive operating cash flow in the past year.
PHI had positive earnings in each of the past 5 years.
Each year in the past 5 years PHI had a positive operating cash flow.
PHI Yearly Net Income VS EBIT VS OCF VS FCFPHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B 80B

1.2 Ratios

PHI has a better Return On Assets (5.08%) than 72.73% of its industry peers.
Looking at the Return On Equity, with a value of 25.73%, PHI belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
PHI's Return On Invested Capital of 8.95% is fine compared to the rest of the industry. PHI outperforms 77.27% of its industry peers.
PHI had an Average Return On Invested Capital over the past 3 years of 5.82%. This is in line with the industry average of 5.84%.
The 3 year average ROIC (5.82%) for PHI is below the current ROIC(8.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.08%
ROE 25.73%
ROIC 8.95%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
PHI Yearly ROA, ROE, ROICPHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 14.61%, PHI belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Profit Margin of PHI has grown nicely.
PHI has a Operating Margin of 24.86%. This is amongst the best in the industry. PHI outperforms 90.91% of its industry peers.
PHI's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 86.48%, PHI belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Gross Margin of PHI has remained more or less at the same level.
Industry RankSector Rank
OM 24.86%
PM (TTM) 14.61%
GM 86.48%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
PHI Yearly Profit, Operating, Gross MarginsPHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHI is creating value.
Compared to 1 year ago, PHI has about the same amount of shares outstanding.
Compared to 5 years ago, PHI has about the same amount of shares outstanding.
Compared to 1 year ago, PHI has a worse debt to assets ratio.
PHI Yearly Shares OutstandingPHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
PHI Yearly Total Debt VS Total AssetsPHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

PHI has an Altman-Z score of 0.80. This is a bad value and indicates that PHI is not financially healthy and even has some risk of bankruptcy.
PHI has a worse Altman-Z score (0.80) than 68.18% of its industry peers.
PHI has a debt to FCF ratio of 27.81. This is a negative value and a sign of low solvency as PHI would need 27.81 years to pay back of all of its debts.
PHI has a worse Debt to FCF ratio (27.81) than 72.73% of its industry peers.
A Debt/Equity ratio of 2.55 is on the high side and indicates that PHI has dependencies on debt financing.
The Debt to Equity ratio of PHI (2.55) is worse than 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF 27.81
Altman-Z 0.8
ROIC/WACC3.33
WACC2.69%
PHI Yearly LT Debt VS Equity VS FCFPHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B 300B

2.3 Liquidity

A Current Ratio of 0.37 indicates that PHI may have some problems paying its short term obligations.
PHI has a Current ratio of 0.37. This is amonst the worse of the industry: PHI underperforms 90.91% of its industry peers.
PHI has a Quick Ratio of 0.37. This is a bad value and indicates that PHI is not financially healthy enough and could expect problems in meeting its short term obligations.
PHI has a worse Quick ratio (0.35) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.35
PHI Yearly Current Assets VS Current LiabilitesPHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

3

3. Growth

3.1 Past

PHI shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.23%.
Measured over the past 5 years, PHI shows a small growth in Earnings Per Share. The EPS has been growing by 5.18% on average per year.
PHI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.02%.
The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)4.23%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%3.61%
Revenue 1Y (TTM)2.02%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%2.46%

3.2 Future

The Earnings Per Share is expected to grow by 3.26% on average over the next years.
The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y-0.33%
EPS Next 2Y2.4%
EPS Next 3Y3.26%
EPS Next 5YN/A
Revenue Next Year1.93%
Revenue Next 2Y2.5%
Revenue Next 3Y2.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PHI Yearly Revenue VS EstimatesPHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B 200B
PHI Yearly EPS VS EstimatesPHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50 100 150

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 6.81, which indicates a rather cheap valuation of PHI.
Based on the Price/Earnings ratio, PHI is valued cheaper than 100.00% of the companies in the same industry.
PHI is valuated cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.49, the valuation of PHI can be described as very cheap.
Based on the Price/Forward Earnings ratio, PHI is valued cheaper than 95.45% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.32. PHI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.81
Fwd PE 6.49
PHI Price Earnings VS Forward Price EarningsPHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

77.27% of the companies in the same industry are more expensive than PHI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHI is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 19.02
EV/EBITDA 5.1
PHI Per share dataPHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.32
EPS Next 2Y2.4%
EPS Next 3Y3.26%

6

5. Dividend

5.1 Amount

PHI has a Yearly Dividend Yield of 8.52%, which is a nice return.
PHI's Dividend Yield is rather good when compared to the industry average which is at 8.48. PHI pays more dividend than 95.45% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, PHI pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.52%

5.2 History

The dividend of PHI has a limited annual growth rate of 5.62%.
PHI has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)5.62%
Div Incr Years0
Div Non Decr Years0
PHI Yearly Dividends per sharePHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

PHI pays out 65.46% of its income as dividend. This is not a sustainable payout ratio.
PHI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP65.46%
EPS Next 2Y2.4%
EPS Next 3Y3.26%
PHI Yearly Income VS Free CF VS DividendPHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B -20B 30B
PHI Dividend Payout.PHI Dividend Payout, showing the Payout Ratio.PHI Dividend Payout.PayoutRetained Earnings

PLDT INC-SPON ADR

NYSE:PHI (10/3/2025, 8:04:00 PM)

After market: 19 0 (0%)

19

+0.32 (+1.71%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)08-12 2025-08-12/dmh
Earnings (Next)11-12 2025-11-12
Inst Owners5.28%
Inst Owner Change-0.01%
Ins Owners0.81%
Ins Owner ChangeN/A
Market Cap4.11B
Analysts80
Price Target29.1 (53.16%)
Short Float %0.23%
Short Ratio2.11
Dividend
Industry RankSector Rank
Dividend Yield 8.52%
Yearly Dividend1.66
Dividend Growth(5Y)5.62%
DP65.46%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.841381)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.94%
Min EPS beat(2)-3.5%
Max EPS beat(2)5.39%
EPS beat(4)1
Avg EPS beat(4)0.11%
Min EPS beat(4)-3.5%
Max EPS beat(4)5.39%
EPS beat(8)4
Avg EPS beat(8)4.11%
EPS beat(12)8
Avg EPS beat(12)11.51%
EPS beat(16)12
Avg EPS beat(16)12.61%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.31%
PT rev (3m)-5.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)0.95%
EPS NY rev (3m)-4.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 6.81
Fwd PE 6.49
P/S 1.09
P/FCF 19.02
P/OCF 3.07
P/B 1.91
P/tB 3.97
EV/EBITDA 5.1
EPS(TTM)2.79
EY14.68%
EPS(NY)2.93
Fwd EY15.42%
FCF(TTM)1
FCFY5.26%
OCF(TTM)6.19
OCFY32.56%
SpS17.49
BVpS9.93
TBVpS4.79
PEG (NY)N/A
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA 5.08%
ROE 25.73%
ROCE 11.94%
ROIC 8.95%
ROICexc 9.18%
ROICexgc 10.74%
OM 24.86%
PM (TTM) 14.61%
GM 86.48%
FCFM 5.71%
ROA(3y)3.73%
ROA(5y)3.92%
ROE(3y)20.92%
ROE(5y)21.02%
ROIC(3y)5.82%
ROIC(5y)6.78%
ROICexc(3y)6.02%
ROICexc(5y)7.44%
ROICexgc(3y)7.16%
ROICexgc(5y)9.04%
ROCE(3y)7.76%
ROCE(5y)9.05%
ROICexcg growth 3Y-2.13%
ROICexcg growth 5Y-4.68%
ROICexc growth 3Y-0.98%
ROICexc growth 5Y-2.62%
OM growth 3Y1.9%
OM growth 5Y0.33%
PM growth 3Y2.8%
PM growth 5Y2.3%
GM growth 3Y-1.41%
GM growth 5Y-0.63%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 2.55
Debt/FCF 27.81
Debt/EBITDA 2.82
Cap/Depr 111.87%
Cap/Sales 29.66%
Interest Coverage 4.4
Cash Conversion 68.86%
Profit Quality 39.1%
Current Ratio 0.37
Quick Ratio 0.35
Altman-Z 0.8
F-Score6
WACC2.69%
ROIC/WACC3.33
Cap/Depr(3y)117.23%
Cap/Depr(5y)139.41%
Cap/Sales(3y)38.48%
Cap/Sales(5y)42.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.23%
EPS 3Y5.37%
EPS 5Y5.18%
EPS Q2Q%3.61%
EPS Next Y-0.33%
EPS Next 2Y2.4%
EPS Next 3Y3.26%
EPS Next 5YN/A
Revenue 1Y (TTM)2.02%
Revenue growth 3Y4.1%
Revenue growth 5Y5.09%
Sales Q2Q%2.46%
Revenue Next Year1.93%
Revenue Next 2Y2.5%
Revenue Next 3Y2.56%
Revenue Next 5YN/A
EBIT growth 1Y25.95%
EBIT growth 3Y6.08%
EBIT growth 5Y5.44%
EBIT Next Year100.62%
EBIT Next 3Y28.53%
EBIT Next 5YN/A
FCF growth 1Y157.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.95%
OCF growth 3Y-3.86%
OCF growth 5Y3.33%